170 related articles for article (PubMed ID: 3495185)
1. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice.
Barral-Netto M; de Freitas LA; Andrade ZA
Am J Pathol; 1987 May; 127(2):271-8. PubMed ID: 3495185
[TBL] [Abstract][Full Text] [Related]
2. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Scott P; Pearce E; Natovitz P; Sher A
J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
[TBL] [Abstract][Full Text] [Related]
4. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.
Russell DG; Alexander J
J Immunol; 1988 Feb; 140(4):1274-9. PubMed ID: 3257774
[TBL] [Abstract][Full Text] [Related]
5. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
[TBL] [Abstract][Full Text] [Related]
6. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages.
Reis MG; Roters SB; Barral-Netto M
Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370
[TBL] [Abstract][Full Text] [Related]
7. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis.
Barral-Netto M; Cardoso SA; Barral A
Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839
[TBL] [Abstract][Full Text] [Related]
8. Leishsmania (Leishmania) amazonensis infection: Muscular involvement in BALB/c and C3H.HeN mice.
Silva-Almeida M; Carvalho LO; Abreu-Silva AL; d'Escoffier LN; Calabrese KS
Exp Parasitol; 2010 Mar; 124(3):315-8. PubMed ID: 19944691
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
Titus RG; Lima GC; Engers HD; Louis JA
J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
Alexander J; Kaye PM
Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
[TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
12. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the host response to Leishmania mexicana.
Pérez H
Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
[TBL] [Abstract][Full Text] [Related]
14. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
Hernández-Chinea C
Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
[TBL] [Abstract][Full Text] [Related]
15. Leishmania amazonensis infection: a comparison of in vivo leishmanicidal mechanisms between immunized and naive infected BALB/c mice.
Pompeu ML; Freitas LA; Santos ML; Barral A; Barral-Netto M
Exp Parasitol; 1992 Mar; 74(2):169-76. PubMed ID: 1740178
[TBL] [Abstract][Full Text] [Related]
16. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
Mazumdar T; Anam K; Ali N
Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
[TBL] [Abstract][Full Text] [Related]
17. Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis.
Fedeli CE; Ferreira JH; Mussalem JS; Longo-Maugéri IM; Gentil LG; dos Santos MR; Katz S; Barbiéri CL
Exp Parasitol; 2010 Feb; 124(2):153-8. PubMed ID: 19735658
[TBL] [Abstract][Full Text] [Related]
18. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
[TBL] [Abstract][Full Text] [Related]
19. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan.
Pinheiro RO; Pinto EF; de Matos Guedes HL; Filho OA; de Mattos KA; Saraiva EM; de Mendonça SC; Rossi-Bergmann B
Vaccine; 2007 Mar; 25(14):2716-22. PubMed ID: 16814903
[TBL] [Abstract][Full Text] [Related]
20. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O
Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
